Skip to main content
Top
Published in: Clinical Rheumatology 11/2009

01-11-2009 | Brief Report

IgG subclass serum levels in systemic lupus erythematosus patients

Authors: Gui-gao Lin, Jin-ming Li

Published in: Clinical Rheumatology | Issue 11/2009

Login to get access

Abstract

IgG subclass levels of sera from 105 patients with systemic lupus erythematosus (SLE) were determined by immunonephelometric assay. Patients were divided into two groups according to clinical activity of the disease: active disease and remission. Forty-five normal controls were also measured. We found a significant increase of IgG1 (p = 0.000), IgG2 (p = 0.000), and IgG3 (p = 0.000) in SLE sera, while IgG4 (p = 0.494) values did not differ significantly from those of controls. When patients were divided according to clinical activity, decrease of IgG3 concentration was observed in the patients in remission. In contrast, the concentrations of IgG1, IgG2, and IgG4 subclass were similar between the two groups (p > 0.05). Our data suggest that differential increase of IgG subclasses during the course of SLE may be of relevance to the pathogenesis of the disease.
Literature
1.
go back to reference Kay RA, Wood KJ, Bernstein RM, Holt PJ, Pumphrey RS (1988) An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 47:536–541PubMedCrossRef Kay RA, Wood KJ, Bernstein RM, Holt PJ, Pumphrey RS (1988) An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 47:536–541PubMedCrossRef
2.
go back to reference Bijl M, Dijstelbloem HM, Oost WW, Bootsma H, Derksen RH, Aten J, Limburg PC, Kallenberg CG (2002) IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus. Rheumatology (Oxford) 41:62–67CrossRef Bijl M, Dijstelbloem HM, Oost WW, Bootsma H, Derksen RH, Aten J, Limburg PC, Kallenberg CG (2002) IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus. Rheumatology (Oxford) 41:62–67CrossRef
3.
go back to reference Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T (2002) Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936–942PubMedCrossRef Kuroki A, Shibata T, Honda H, Totsuka D, Kobayashi K, Sugisaki T (2002) Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 41:936–942PubMedCrossRef
4.
go back to reference Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA (2001) An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 40:1405–1412CrossRef Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA (2001) An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 40:1405–1412CrossRef
5.
go back to reference Loizou S, Cofiner C, Weetman AP, Walport MJ (1992) Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 90:434–439PubMed Loizou S, Cofiner C, Weetman AP, Walport MJ (1992) Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 90:434–439PubMed
6.
go back to reference Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, Shao FM, Zhao MH (2009) Anti-c1q antibodies and IgG subclass distribution in sera from chinese patients with lupus nephritis. Nephrol Dial Transplant 24:172–178PubMedCrossRef Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, Shao FM, Zhao MH (2009) Anti-c1q antibodies and IgG subclass distribution in sera from chinese patients with lupus nephritis. Nephrol Dial Transplant 24:172–178PubMedCrossRef
7.
go back to reference Tsujimura M, Tokano Y, Takasaki Y, Hashimoto H (1997) The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 20:8–13PubMed Tsujimura M, Tokano Y, Takasaki Y, Hashimoto H (1997) The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus. Nihon Rinsho Meneki Gakkai Kaishi 20:8–13PubMed
8.
go back to reference Blanco F, Kalsi J, Ravirajan CT, Speight P, Bradwell AR, Isenberg DA (1992) IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1:391–399PubMedCrossRef Blanco F, Kalsi J, Ravirajan CT, Speight P, Bradwell AR, Isenberg DA (1992) IgG subclasses in systemic lupus erythematosus and other autoimmune rheumatic diseases. Lupus 1:391–399PubMedCrossRef
9.
go back to reference Pressac M, Allouche F, Circaud R, Aymard P (1995) Evaluation of human IgG subclass assays on Beckman array. Ann Clin Biochem 32:281–288PubMed Pressac M, Allouche F, Circaud R, Aymard P (1995) Evaluation of human IgG subclass assays on Beckman array. Ann Clin Biochem 32:281–288PubMed
10.
go back to reference Hochberg MC (1997) Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef Hochberg MC (1997) Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRef
11.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMedCrossRef
12.
go back to reference Manolova I, Dancheva M, Halacheva K (2002) Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus. Rheumatol Int 21:227–233PubMedCrossRef Manolova I, Dancheva M, Halacheva K (2002) Predominance of IgG1 and IgG3 subclasses of autoantibodies to neutrophil cytoplasmic antigens in patients with systemic lupus erythematosus. Rheumatol Int 21:227–233PubMedCrossRef
13.
go back to reference Tiikkainen U, Wangel A, Appleton SL, Arthur D (1991) Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus. Scand J Immunol 34:265–271PubMedCrossRef Tiikkainen U, Wangel A, Appleton SL, Arthur D (1991) Subclasses of IgG anticardiolipin antibodies in patients with systemic lupus erythematosus. Scand J Immunol 34:265–271PubMedCrossRef
14.
go back to reference Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC (2000) Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 43:76–84PubMedCrossRef Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC (2000) Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum 43:76–84PubMedCrossRef
Metadata
Title
IgG subclass serum levels in systemic lupus erythematosus patients
Authors
Gui-gao Lin
Jin-ming Li
Publication date
01-11-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1224-x

Other articles of this Issue 11/2009

Clinical Rheumatology 11/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.